WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) traded up 2.1% on Thursday . The stock traded as high as $14.26 and last traded at $14.1650. 1,785 shares were traded during trading, a decline of 41% from the average session volume of 3,031 shares. The stock had previously closed at $13.87.
Wall Street Analyst Weigh In
Separately, The Goldman Sachs Group raised WuXi AppTec to a “buy” rating in a research report on Thursday. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy”.
Read Our Latest Research Report on WUXAY
WuXi AppTec Stock Performance
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Read More
- Five stocks we like better than WuXi AppTec
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The day the gold market broke
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- He just nailed another gold prediction …
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
